Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Teh, Cheryl Ann ^a   Lee, Tih Shih ^b   Kuchibhatla, Margaratha ^b   Ashley Koch, Allison ^b   MacFall, James ^b   Krishnan, Ranga ^a,b   Beyer, John ^b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; BRAIN; BRAIN MORPHOLOGY; BRAIN REGION; BRAIN SIZE; CAUCASIAN; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GRAY MATTER; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; SAMPLE SIZE; WHITE MATTER;

ADULT; AGED; AMINO ACID SUBSTITUTION; BIPOLAR DISORDER; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84864458650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038469     Document Type: Article

References (45)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE, ((2005)) Prevalence, Severity and Comorbidity of 12 month DSM-IV Disorders in the National Co-morbidity Survey Replication. Arch Gen Psychiatry 62(6):: 617--27.
2. Beyer JL, Kuchibhatla M, Payne ME, Macfall J, Cassidy F, et al. ((2009)) Gray and white matter brain volumes in older adults with bipolar disorder. Int J Ger Psychiatry 24(12):: 1445--1452.
3. Heng S, Song AW, Sim K, ((2010)) White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies. J Neural Transm 117(5):: 639--54.
4. Kempton M, Gettes JR, Ettinger U, Williams SCR, Grasby PM, ((2008)) Meta-analysis, database and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 65(9):: 1017--32.
5. Ellison-Wright I, Bullmore E, ((2010)) Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 117(1):: 1--12.
6. Savitz J, Nugent AC, Bogers W, Liu A, Sills R, et al. ((2010)) Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Neuroimage 49(4):: 2966--76.
7. Chepenik LG, Fredericks C, Papademetris X, Spencer L, Lacadie C, et al. ((2009)) Effects of BDNF Val66Met variation on Hippocampus Morphology in Bipolar Disorder. Neuropsychopharmacology 34(4):: 944--51.
8. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, et al. ((2002)) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 7(6):: 579--93.
9. Green EK, Raybould R, ((2006)) Genetic variation of Brain-derived Neurotrophic Factor (BDNF) in bipolar disorder: Case-control study of over 3000 individuals from the UK. British Journal of Psychiatry 188:: 21--25.
10. Schultz W, ((2006)) Behavioral theories and the neurophysiology of reward. Annu Rev Psycho 57:: 87--115.
11. Lin PY, ((2009)) State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study. Neurosci Lett 466(3): 139-43. Epub Sep 26.
12. Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, et al. ((2011)) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45(8): 995-1004. Epub 2011 May 6.
13. Tramontina J, Frey BN, Andreazza AC, Zandona M, Santin A, Kapczinski F, ((2007)) Val66met polymorphism and serum brain-derived neurotrophic factor levels in bipolar disorder. Mol Psychiatry 12:: 230--231.
14. Bath KG, Lee FS, ((2006)) Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci 6(1):: 79--85.
15. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, ((2005)) Association of a functional BDNF polymorphism and anxiety related personality traits. Psychopharmacology (Berl) 180:: 95--9.
16. Montag C, Basten U, Stelzel C, Fiebach CJ, Reuter M, ((2010)) The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans. Psychiatry Res 179(1):: 86--90.
17. Ho BM, ((2006)) Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63:: 731--740.
18. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM, ((2006)) The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 27:: 1834--1837.
19. Taylor WD, Zuchner S, McQuoid DR, Steffens DC, Speer M, et al. ((2007)) Allelic differences in the BDNF val66met polymorphism in late-life depression. Am J Geriatr Psychiatry 2007 15:: 850--857.
20. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, et al. ((2010)) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15(3):: 260--71.
21. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL, ((2002)) The BDNF gene confers susceptibility to Bipolar Disorder: Evidence from a Family-based Association Study. Am J Hum Genet 71(3):: 651--5.
22. Liu L, Foroud T, Xuei X, Berrettini W, Byerley W, et al. ((2008)) Evidence of association between BDNF gene and bipolar disorder Psychiatr Genet. 18(6):: 267--74.
23. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, et al. ((2004)) The BDNF Val66Met polymorphism and variation in human cortical morphology. J Neurosci 24:: 10099--102.
24. Montag C, Weber B, Fliessbach K, Elger C, Reuter M, ((2009)) The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: Incremental support for a genetic risk factor for depression. Psychol Med 38:: 1831--9.
25. Benjamin S, McQuoid DR, Potter GG, Payne ME, MacFall JR, et al. ((2010)) BDNF Val66Met polymorphism, hippocampal volume and cognitive function in Geriatric Depression. Am J Geriatr Psychiatry 18(4):: 323--31.
26. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, ((2003)) The BDNF val66met polymorphism affects activity dependent secretion of BDNF and human memory and hippocampal function Cell. 112:: 257--269.
27. Chen ZY, Patel PD, Sant G, Meng CX, Teng KK, et al. ((2004)) Variant brain-derived neurotrophic factor (BDNF) Met66 alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons J Neurosci. 24:: 4401--4411.
28. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, ((2005)) BDNF Val66Met polymorphism and volume of hippocampal formation. Mol Psychiatry 10:: 631--36.
29. Frodl T, Schule C, Schmitt G, Born C, Baghai T, et al. ((2007)) Association of the Brain-derived Neurotrophic Factor Val66Met Polymorphism with Reduced Hippocampal Volumes in Major Depression. Arch Gen Psychiatry 64(4):: 410--416.
30. Matsuo K, Walss-Bass C, Nery FG, Nicoletti MA, Hatch JP, ((2009)) Neuronal correlates of BDNF Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 34(8):: 1904--13.
31. Taylor WD, Züchner S, McQuoid DR, Steffens DC, Blazer DG, et al. ((2008)) Social support in older individuals: The role of BDNF Val66Met Polymorphism. Am J Med Genet B Neuropsychiatr Genet 147B:: 1205--21.
32. Taylor WD, Züchner S, McQuoid DR, Payne ME, MacFall JR, ((2008)) The BDNF Val66Met polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry 16(4):: 263--271.
33. Taylor WD, McQuoid DR, Ashley-Koch A, MacFall JR, Bridgers J, et al. ((2011)) BDNF Val66Met genotype and 6-month remission rates in late life depression. Pharmacogenomics J 11(2):: 146--54.
34. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008) New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 59(1):: 201--20.
35. American PsychiatricAssociation (1994) Diagnostic and statistical manual of mental disorders fourth edition DSM-IV. Amercian Psychiatric Association. Washington DC.
36. Folstein MF, Folstein SE, McHugh PR, ((1975)) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):: 189--98.
37. Radloff LS, ((1977)) The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement 1 (3):: 385--401.
38. Rimmler JM, McDowell JG, Slotterback BD, Haynes CS, Menold MM, et al. ((1998)) Development of a data coordinating centre (DCC): data quality control for complex disease studies. Am J Hum Genet. Suppl 63pp. A240.
39. Strakowski SM, DelBello MP, Adler C, Cecil KM, Sax KW, ((2000)) Neuroimaging in bipolar disorder. Bipolar Disord 2:: 148--164.
40. Buckley P, ((2005)) Neuroimaging of schizophrenia: Structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat 1(3):: 193--204.
41. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM, ((2002)) Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry 52(2):: 93--100.
42. Toro R, Chupin M, Garnero L, Leonard G, Perron M, et al. ((2009)) Brain volumes and Val66Met polymorphism of BDNF gene: local or global effects? Brain Struct Funct 213(6):: 501--509.
43. RosnerB (2000) Fundamentals of Biostatistics. Belmont, CA: Duxbury Press 792 p.
44. Bearden CE, Thompson PM, Dalwani M, Hayashi KM, Lee AD, ((2007)) Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62:: 7--16.
45. Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, et al. ((2007)) Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett 429(1):: 7--11.